CLINICAL_TRIALS
trial_result
· 2015-04-28
Clinical Trial Update: Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer [Phase 2]
Summary
A Phase 2 study evaluating WST11 in patients with obstructing endobronchial non-small cell lung cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Steba Biotech S.A. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED